GlaxoSmithKline to Buy Tesaro for $5.1 Billion

07.12.2018 - UK drugmaker GlaxoSmithKline (GSK) has entered into a definitive agreement to acquire Tesaro, a commercial-stage biopharmaceutical company based in Waltham, Massachusetts, USA, for...